Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Murepavadin by Spexis for Bronchiectasis: Likelihood of Approval
Murepavadin is under clinical development by Spexis and currently in Phase I for Bronchiectasis. According to GlobalData, Phase I drugs...